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These books contain most of the papers presented 
at three recent symposia or workshops devoted to 
topics in inflammation research. They are published 
as supplements to the Swiss-based pharmacological 
journal Agents and Actions and, as the blurb says, the 
aim is for rapid publication at a reasonable price. For 
this reason the papers are photographically reproduced 
direct from the authors’manuscripts. Predictably, this 
means that the standard is very variable - in terms of 
scope, style, interest and presentation. The indexes 
are very sketchy. However, authors, editors and pub- 
lishers have done well to get these books out within 
9-12 months of the conferences. 
Supplement 4 concerns arachidonate metabolism 
in inflammation and thrombosis. The 30 papers are 
grouped into three sections: Liberation of arachidonic 
acid and mode of action of glucocorticoid hormones 
(there was much interest at the time of the meeting 
that anti-inflammatory effects of glucocorticoids may 
partly be due to protein synthesisdependent inhibition 
of phospholipase action); Effects of drugs on arach- 
idonate metabolism and role in thrombosis and 
inflammation; Actions and functions of arachidonate 
metabolites (a varied rag-bag of papers). 
Much of the coverage of the 21 papers of supple- 
ment 6 is similar. These proceedings are divided into 
five sections: Metabolism of arachidonic acid (path- 
ways, identification of slow reacting substance); Pros- 
taglandins as mediators of acute inflammation and 
pain; Prostaglandins and chronic inflammation; Effects 
of anti-inflammatory drugs and prostaglandin produc- 
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tion; Prostaglandins and side effects of anti-inflamma- 
tory drugs. Five of the research groups appear in both 
volumes and there is a definite sense of deja vu. 
Supplement 5 is very different. It is more special- 
ised and concerns connective tissue, penicillamine and 
rheumatoid arthritis. There are useful reviews of col- 
lagen metabolism and the mechanisms of macrophage 
activation and tissue destruction, and several papers 
on the effects and actions of slow-acting drugs used 
for the treatment of rheumatoid arthritis and other 
allied chronic inflammatory conditions. 
Who is going to buy these books? They are not 
suitable as general reviews of the subjects covered since 
they are restricted ‘state of the art’ collections. As such 
they will be of use to workers in the field who find it 
handy to have papers grouped together, rather than 
to have to search the literature. I guess they will fmd 
a place in academic and industrial laboratories con- 
cerned with prostaglandin and inflammation research. 
Since it is likely that much of the material described 
will rapidly become obsolete it might be worthwhile 
for the publishers to consider ways of speeding up 
and/or reducing the cost of publication: perhaps a 
journal-style paper-covered magazine might be the best 
answer. The’fact of the matter is that symposia are 
usually much more exciting on the day. The proceed- 
ings often turn out to be rather indifferent and expen- 
sive, if not actually out of data. Moreover the articles 
haven’t been refereed - and this often shows. 
Robin Hoult 
